Cancer Letters, 1872-7980

Tidskrift

Fler filtreringsmöjligheter
  1. 2020
  2. ASCL1 promotes tumor progression through cell-autonomous signaling and immune modulation in a subset of lung adenocarcinoma

    Naoya Miyashita, Masafumi Horie, Yu Mikami, Hirokazu Urushiyama, Kensuke Fukuda, Kazuko Miyakawa, Hirotaka Matsuzaki, Kosuke Makita, Yasuyuki Morishita, Hiroaki Harada, Max Backman, Cecilia Lindskog, Hans Brunnström, Patrick Micke, Takahide Nagase & Akira Saito, 2020, I: Cancer Letters. 489, s. 121-132 12 s.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  3. 2019
  4. Modulation of lung cancer cell plasticity and heterogeneity with the restoration of cisplatin sensitivity by neurotensin antibody

    Zherui Wu, Ludovic Fournel, Nicolas Stadler, Jin Liu, Agnès Boullier, Nadia Hoyeau, Jean François Fléjou, Véronique Duchatelle, Nouzha Djebrani-Oussedik, Mikaël Agopiantz, Evelyne Ségal-Bendirdjian, Anne Gompel, Marco Alifano, Olle Melander, Jean Trédaniel & Patricia Forgez, 2019, I: Cancer Letters. 444, s. 147-161 15 s.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  5. 2018
  6. Montelukast, a CysLT1 receptor antagonist, reduces colon cancer stemness and tumor burden in a mouse xenograft model of human colon cancer

    Kishan Bellamkonda, Shakti Ranjan Satapathy, Desiree Douglas, Naveenkumar Chandrashekar, Benson Chellakkan Selvanesan, Minghui Liu, Sayeh Savari, Gunilla Jonsson & Anita Sjölander, 2018 nov 28, I: Cancer Letters. 437, s. 13-24 12 s.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  7. 2017
  8. Efficacy of the CDK inhibitor dinaciclib in vitro and in vivo in T-cell acute lymphoblastic leukemia

    Sausan A. Moharram, Kinjal Shah, Fatima Khanum, Alissa Marhäll, Gazi Mohiuddin & Julhash U. Kazi, 2017 okt 1, I: Cancer Letters. 405, s. 73-78 6 s.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  9. The dual specificity PI3K/mTOR inhibitor PKI-587 displays efficacy against T-cell acute lymphoblastic leukemia (T-ALL)

    Gazi Mohiuddin, Sausan A. Moharram, Alissa Marhäll & Julhash U. Kazi, 2017 apr 28, I: Cancer Letters. 392, s. 9-16 8 s.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  10. MicroRNAs as cancer therapeutics: A step closer to clinical application

    Tina Catela Ivkovic, Gjendine Voss, Helena Cornella & Yvonne Ceder, 2017, I: Cancer Letters. 407, s. 113-122

    Forskningsoutput: TidskriftsbidragÖversiktsartikel

  11. 2016
  12. Genetic variation in the major mitotic checkpoint genes associated with chromosomal aberrations in healthy humans

    Asta Försti, Christoph Frank, Bozena Smolkova, Alena Kazimirova, Magdalena Barancokova, Veronika Vymetalkova, Michal Kroupa, Alessio Naccarati, Ludmila Vodickova, Janka Buchancova, Maria Dusinska, Ludovit Musak, Pavel Vodicka & Kari Hemminki, 2016 okt 1, I: Cancer Letters. 380, 2, s. 442-446 5 s.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  13. Risk of second primary cancers after malignant mesothelioma and vice versa

    Tianhui Chen, Elham Kharazmi, Jianlin Lou, Xing Zhang, Kristina Sundquist & Kari Hemminki, 2016 aug 28, I: Cancer Letters. 379, 1, s. 94-99 6 s.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  14. Neuroblastoma patient-derived orthotopic xenografts reflect the microenvironmental hallmarks of aggressive patient tumours

    Noémie Braekeveldt, Caroline Wigerup, Irene Tadeo, Siv Beckman, Caroline Sandén, Jimmie Jönsson, Jonas S Erjefält, Ana P Berbegall, Anna Börjesson, Torbjörn Backman, Ingrid Øra, Samuel Navarro, Rosa Noguera, David Gisselsson, Sven Påhlman & Daniel Bexell, 2016, I: Cancer Letters. 375, 2, s. 384-389

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  15. 2015
  16. Cytokeratin 20 improves the detection of circulating tumor cells in patients with colorectal cancer.

    Charlotte Welinder, Bo Jansson, Gert Lindell & Jörgen Wenner, 2015, I: Cancer Letters. 358, 1, s. 43-46

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  17. Distribution and risk of the second discordant primary cancers combined after a specific first primary cancer in German and Swedish cancer registries.

    Tianhui Chen, Mahdi Fallah, Lina Jansen, Felipe A Castro, Agne Krilavicuite, Alexander Katalinic, Nora Eisemann, Katharina Emrich, Bernd Holleczek, Karla Geiss, Andrea Eberle, Jan Sundquist, Hermann Brenner & Kari Hemminki, 2015, I: Cancer Letters. 369, 1, s. 152-166

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  18. Prognostic impact of COX-2 in non-small cell lung cancer: A comprehensive compartment-specific evaluation of tumor and stromal cell expression.

    Johanna S M Mattsson, Bengt Bergman, Marianna Grinberg, Karolina Edlund, Millaray Marincevic, Karin Jirström, Fredrik Pontén, Jan G Hengstler, Jörg Rahnenführer, Mats G Karlsson, Christina Karlsson, Gisela Helenius, Johan Botling, Patrick Micke & Miklos Gulyas, 2015, I: Cancer Letters. 356, 2, s. 837-845

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  19. The α2β1 binding domain of chondroadherin inhibits breast cancer-induced bone metastases and impairs primary tumour growth: A preclinical study.

    Nadia Rucci, Mattia Capulli, Ole K Olstad, Patrik Önnerfjord, Viveka Tillgren, Kaare M Gautvik, Dick Heinegård & Anna Teti, 2015, I: Cancer Letters. 358, 1, s. 67-75

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  20. 2012
  21. Co-targeting of the PI3K pathway improves the response of BRCA1 deficient breast cancer cells to PARP1 inhibition.

    Siker Kimbung, Ewa Biskup, Ida Johansson, Kristina Aaltonen, Astrid Ottosson-Wadlund, Sofia Gruvberger, Heather Cunliffe, Bengt Fadeel, Niklas Loman, Pontus Berglund & Ingrid Hedenfalk, 2012, I: Cancer Letters. 319, 2, s. 232-241

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  22. 2011
  23. Aberrant DNA methylation of cancer-associated genes in gastric cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC-EURGAST)

    Karen Balassiano, Sheila Lima, Mazda Jenab, Kim Overvad, Anne Tjonneland, Marie Christine Boutron-Ruault, Francoise Clavel-Chapelon, Federico Canzian, Rudolf Kaaks, Heiner Boeing, Karina Meidtner, Antonia Trichopoulou, Pagona Laglou, Paolo Vineis, Salvatore Panico, Domenico Palli, Sara Grioni, Rosario Tumino, Eiliv Lund, H. Bas Bueno-de-Mesquita & 22 andra, Mattjis E. Numans, Petra H. M. Peeters, J. Ramon Quiros, Maria-Jose Sanchez, Carmen Navarro, Eva Ardanaz, Miren Dorronsoro, Goran Hallmans, Roger Stenling, Roy Ehrnström, Sara Regnér, Naomi E. Allen, Ruth C. Travis, Kay-Tee Khaw, G. Johan A. Offerhaus, Nuria Sala, Elio Riboli, Pierre Hainaut, Jean-Yves Scoazec, Bakary S. Sylla, Carlos A. Gonzalez & Zdenko Herceg, 2011, I: Cancer Letters. 311, 1, s. 85-95

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  24. 2010
  25. Galectin inhibitory disaccharides promote tumour immunity in a breast cancer model

    Kimberley A. Stannard, Patrick M. Collins, Koichi Ito, Emily M. Sullivan, Stacy A. Scott, Elwyn Gabutero, I. Darren Grice, Pauline Low, Ulf Nilsson, Hakon Leffler, Helen Blanchard & Stephen J. Ralph, 2010, I: Cancer Letters. 299, 2, s. 95-110

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  26. 2009
  27. Concomitant use of Ad5/35 chimeric oncolytic adenovirus with TRAIL gene and taxol produces synergistic cytotoxicity in gastric cancer cells

    Chen Lin, Dongfeng Chen, Mouchun Gong, Manli Na, Linfang Li, Hongping Wu, Lihua Jiang, Yanzhen Qian, Guoen Fang & Xuchao Xue, 2009, I: Cancer Letters. 284, 2, s. 141-148

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  28. Potentiation of naphthoxyloside cytotoxicity on human tumor cells by difluoromethylornithine and spermine-NONOate.

    Fang Cheng, Richard Johnsson, Jakob Nilsson, Lars-Åke Fransson, Ulf Ellervik & Katrin Mani, 2009, I: Cancer Letters. 273, s. 148-154

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  29. t(3;21)(q22;q22) leading to truncation of the RYK gene in atypical chronic myeloid leukemia

    Francesca Micci, Ioannis Panagopoulos, Lisbeth Haugom, Hege Kilen Andersen, Geir E. Tjonnfjord, Klaus Beiske & Sverre Heim, 2009, I: Cancer Letters. 277, 2, s. 205-211

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  30. 2008
  31. B cell lymphomas express CX(3)CR1 a non-B cell lineage adhesion molecule.

    Ulrika Andreasson, Sara Ek, Hartmut Merz, Richard Rosenquist, Niels Andersen, Mats Jerkeman, Michael Dictor & Carl A K Borrebaeck, 2008, I: Cancer Letters. 259, 2, s. 138-145

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  32. Identification of differentially expressed genes after PPM1D silencing in breast cancer.

    Jenita Pärssinen, Emma-Leena Alarmo, Sofia Khan, Ritva Karhu, Mauno Vihinen & Anne Kallioniemi, 2008, I: Cancer Letters. 259, 1, s. 61-70

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  33. Phenotypic protein profiling of different B cell sub-populations using antibody CD-microarrays

    Peter Ellmark, Carl-Magnus Högerkorp, Sara Ek, Larissa Beelov, Mattias Berglund, Richard Rosenquist, Richard Christopherson & Carl Borrebaeck, 2008, I: Cancer Letters. 265, s. 98-106

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  34. 2007
  35. Fusion genes in angiomatoid fibrous histiocytoma

    Karolin Hansén Nord, Francesca Micci, Jeanne M Meis-Kindblom, Lars-Gunnar Kindblom, Patrizia Bacchini, Nils Mandahl, Fredrik Mertens & Ioannis Panagopoulos, 2007 jun 18, I: Cancer Letters. 251, 1, s. 158-163 6 s.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  36. Low dose Zebularine treatment enhances immunogenicity of tumor cells

    Hua Liu, Zhongtian Xue, Hans Olof Sjögren, Leif Salford & Bengt Widegren, 2007, I: Cancer Letters. 257, 1, s. 107-115

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  37. Papillomavirus type 16 E6/E7 and human telomerase reverse transcriptase in esophageal cell immortalization and early transformation

    Hao Zhang, Yuesheng Jin, Xuehua Chen, Charlotte Jin, Simon Law, Sai-Wah Tsao & Yok-Lam Kwong, 2007, I: Cancer Letters. 245, 1-2, s. 184-194

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  38. 2006
  39. Ursodeoxycholic acid differentially affects three types of sphingomyelinase in human colon cancer Caco 2 cells.

    Fuli Liu, Yajun Cheng, Jun Wu, Horst-Dietmar Tauschel & Rui-Dong Duan, 2006, I: Cancer Letters. 235, 1, s. 141-146

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  40. 2004
  41. Mitotic instability associated with late genomic changes in bone and soft tissue tumours.

    David Gisselsson Nord, Eva Pålsson, Christina Yu, Fredrik Mertens & Nils Mandahl, 2004, I: Cancer Letters. 206, 1, s. 69-76

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  42. Profiling of internalizing tumor-associated antigens on breast and pancreatic cancer cells by reversed genomics

    Johan Fransson, Sara Ek, Peter Ellmark, Eskil Söderlind, Carl Borrebaeck & Christina Furebring, 2004, I: Cancer Letters. 208, 2, s. 235-242

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  43. The Notch signaling cascade in neuroblastoma: role of the basic helix-loop-helix proteins HASH-1 and HES-1.

    Håkan Axelson, 2004, I: Cancer Letters. 204, 2, s. 171-178

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  44. 2003
  45. Hypoxia-induced dedifferentiation in neuroblastoma cells.

    Annika Jögi, Ingrid Øra, Helén Nilsson, Lorenz Poellinger, Håkan Axelson & Sven Påhlman, 2003, I: Cancer Letters. 197, 1-2, s. 145-150

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  46. 1999
  47. Fluorescence diagnostics and kinetic studies in the head and neck region utilizing low-dose delta-aminolevulinic acid sensitization

    I Wang, L. P Clemente, R. M. G Pratas, E Cardoso, M. P Clemente, S Montan, Sune Svanberg & Katarina Svanberg, 1999, I: Cancer Letters. 135, 1, s. 11-19

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  48. 1998
  49. A case of dermatofibrosarcoma protuberans with a ring chromosome 5 and a rearranged chromosome 22 containing amplified COL1A1 and PDGFB sequences

    D Gisselsson, M Höglund, K P O'Brien, J P Dumanski, F Mertens & N Mandahl, 1998 nov 27, I: Cancer Letters. 133, 2, s. 129-34 6 s.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  50. 1997
  51. Pharmacokinetic studies on 5-aminolevulinic acid-induced protoporphyrin IX accumulation in tumours and normal tissues

    H Heyerdahl, I Wang, D. L Liu, R Berg, Stefan Andersson-Engels, Q Peng, J Moan, Sune Svanberg & Katarina Svanberg, 1997, I: Cancer Letters. 112, 2, s. 225-231

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  52. Tumour vessel damage resulting from laser-induced hyperthermia alone and in combination with photodynamic therapy

    D. L Liu, Stefan Andersson-Engels, C Sturesson, Katarina Svanberg, C. H Hakansson & Sune Svanberg, 1997, I: Cancer Letters. 111, 1-2, s. 157-165

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  53. 1996
  54. Repeated immunotherapy using intratumoural injection with recombinant interleukin-2 and tumour-infiltrating lymphocytes inhibits growth of breast cancer and induces apoptosis of tumour cells

    David L. Liu, M. Q. Yang, J. Eberhardt & B. Persson, 1996 jun 5, I: Cancer Letters. 103, 2, s. 131-136 6 s.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  55. 1994
  56. ERBB2 amplification is associated with tamoxifen resistance in steroid-receptor positive breast cancer

    Åke Borg, Bo Baldetorp, Mårten Fernö, Dick Killander, Håkan Olsson, Stefan Ryden & Helgi Sigurdsson, 1994, I: Cancer Letters. 81, 2, s. 137-144

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  57. Release of intracellular calcium and stimulation of cell growth by ATP and histamine in human ovarian cancer cells (SKOV-3)

    Satish Batra & I Fadeel, 1994, I: Cancer Letters. 77, 1, s. 57-63

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  58. 1992
  59. Inhibition of leukocyte phagocytosis by serotonin and its possible role in tumor cell destruction

    U Nannmark, L Sennerby, Lars Magnus Bjursten, G Skolnik & U Bagge, 1992, I: Cancer Letters. 62, 1, s. 83-86

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift